| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 5 | 2025 | 340 | 2.780 |
Why?
|
| Lung Neoplasms | 5 | 2025 | 495 | 2.480 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2026 | 25 | 2.100 |
Why?
|
| Carotid Stenosis | 4 | 2025 | 16 | 2.060 |
Why?
|
| Predictive Value of Tests | 11 | 2026 | 440 | 2.040 |
Why?
|
| Carotid Artery Diseases | 3 | 2025 | 26 | 2.040 |
Why?
|
| Prognosis | 14 | 2026 | 861 | 2.030 |
Why?
|
| Ultrasonography | 14 | 2025 | 135 | 1.830 |
Why?
|
| Echocardiography | 16 | 2025 | 167 | 1.710 |
Why?
|
| Neovascularization, Pathologic | 5 | 2025 | 139 | 1.580 |
Why?
|
| Nomograms | 2 | 2024 | 14 | 1.580 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2025 | 133 | 1.570 |
Why?
|
| Neoplasms | 5 | 2024 | 1377 | 1.440 |
Why?
|
| Risk Assessment | 9 | 2026 | 863 | 1.390 |
Why?
|
| DNA Methylation | 4 | 2024 | 403 | 1.380 |
Why?
|
| Humans | 68 | 2026 | 43102 | 1.270 |
Why?
|
| Aged | 25 | 2026 | 8214 | 1.250 |
Why?
|
| Middle Aged | 35 | 2026 | 12222 | 1.210 |
Why?
|
| Recurrence | 3 | 2025 | 152 | 1.100 |
Why?
|
| Female | 46 | 2026 | 24698 | 1.030 |
Why?
|
| Male | 39 | 2026 | 23409 | 1.010 |
Why?
|
| Stroke Volume | 4 | 2025 | 122 | 1.000 |
Why?
|
| Sulfites | 3 | 2024 | 13 | 0.990 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2026 | 20 | 0.970 |
Why?
|
| Endarterectomy, Carotid | 1 | 2025 | 2 | 0.930 |
Why?
|
| Heart Block | 1 | 2025 | 4 | 0.930 |
Why?
|
| Fetal Heart | 1 | 2025 | 4 | 0.930 |
Why?
|
| Antibodies, Antinuclear | 1 | 2025 | 17 | 0.920 |
Why?
|
| Stents | 1 | 2025 | 67 | 0.890 |
Why?
|
| Sulfur Hexafluoride | 7 | 2018 | 7 | 0.880 |
Why?
|
| Computational Biology | 3 | 2024 | 327 | 0.880 |
Why?
|
| Atrial Fibrillation | 1 | 2026 | 122 | 0.860 |
Why?
|
| Retrospective Studies | 8 | 2026 | 2544 | 0.860 |
Why?
|
| Contrast Media | 9 | 2025 | 103 | 0.840 |
Why?
|
| Immunotherapy | 2 | 2024 | 144 | 0.830 |
Why?
|
| Phospholipids | 7 | 2018 | 70 | 0.830 |
Why?
|
| Peptide Fragments | 1 | 2026 | 307 | 0.820 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2024 | 34 | 0.820 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 704 | 0.810 |
Why?
|
| Cardiovascular System | 1 | 2024 | 37 | 0.810 |
Why?
|
| RNA, Small Interfering | 1 | 2025 | 436 | 0.780 |
Why?
|
| Risk Factors | 8 | 2026 | 3994 | 0.770 |
Why?
|
| Pulmonary Fibrosis | 1 | 2022 | 38 | 0.760 |
Why?
|
| Software | 1 | 2024 | 236 | 0.750 |
Why?
|
| Severity of Illness Index | 2 | 2024 | 719 | 0.750 |
Why?
|
| Transcription Factors | 2 | 2024 | 735 | 0.720 |
Why?
|
| Heart Failure | 1 | 2025 | 302 | 0.680 |
Why?
|
| Prospective Studies | 10 | 2025 | 1600 | 0.660 |
Why?
|
| Organ Specificity | 1 | 2020 | 141 | 0.660 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 2853 | 0.640 |
Why?
|
| Genomics | 2 | 2020 | 293 | 0.640 |
Why?
|
| Metals | 1 | 2020 | 114 | 0.630 |
Why?
|
| Myocardial Perfusion Imaging | 2 | 2018 | 6 | 0.610 |
Why?
|
| Research | 1 | 2020 | 181 | 0.590 |
Why?
|
| Models, Theoretical | 1 | 2020 | 232 | 0.590 |
Why?
|
| Ventricular Dysfunction, Left | 4 | 2024 | 96 | 0.590 |
Why?
|
| Lipids | 1 | 2020 | 256 | 0.580 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 58 | 0.570 |
Why?
|
| Mutation | 2 | 2023 | 1177 | 0.550 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 89 | 0.540 |
Why?
|
| Aorta | 4 | 2018 | 198 | 0.540 |
Why?
|
| Reproducibility of Results | 13 | 2020 | 1081 | 0.520 |
Why?
|
| Time Factors | 4 | 2026 | 1857 | 0.510 |
Why?
|
| Heart Ventricles | 5 | 2020 | 123 | 0.470 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 291 | 0.470 |
Why?
|
| Echocardiography, Doppler | 3 | 2020 | 41 | 0.470 |
Why?
|
| Adult | 27 | 2026 | 13872 | 0.470 |
Why?
|
| Endothelium, Vascular | 3 | 2018 | 263 | 0.450 |
Why?
|
| Follow-Up Studies | 4 | 2026 | 1067 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2024 | 968 | 0.440 |
Why?
|
| Thrombosis | 1 | 2015 | 81 | 0.430 |
Why?
|
| Myocardial Contraction | 2 | 2016 | 46 | 0.430 |
Why?
|
| Aorta, Abdominal | 2 | 2014 | 17 | 0.430 |
Why?
|
| Ventricular Function, Left | 5 | 2024 | 114 | 0.430 |
Why?
|
| Ultrasonography, Mammary | 4 | 2022 | 8 | 0.410 |
Why?
|
| Carotid Arteries | 2 | 2024 | 36 | 0.410 |
Why?
|
| Sensitivity and Specificity | 10 | 2022 | 611 | 0.410 |
Why?
|
| Aneurysm, False | 2 | 2003 | 4 | 0.400 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 1723 | 0.390 |
Why?
|
| Heart Valve Diseases | 3 | 2018 | 15 | 0.390 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 512 | 0.390 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 2003 | 25 | 0.380 |
Why?
|
| Treatment Outcome | 4 | 2025 | 1604 | 0.380 |
Why?
|
| Aortic Valve | 3 | 2018 | 38 | 0.380 |
Why?
|
| Ascorbic Acid | 2 | 2003 | 74 | 0.380 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2023 | 35 | 0.370 |
Why?
|
| Losartan | 2 | 2002 | 35 | 0.370 |
Why?
|
| Disease-Free Survival | 2 | 2024 | 116 | 0.360 |
Why?
|
| Coronary Vessels | 2 | 2002 | 92 | 0.360 |
Why?
|
| Heart Neoplasms | 3 | 2018 | 8 | 0.340 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 1092 | 0.340 |
Why?
|
| Image Enhancement | 3 | 2015 | 37 | 0.320 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2025 | 40 | 0.320 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 291 | 0.320 |
Why?
|
| Coronary Artery Disease | 3 | 2024 | 163 | 0.310 |
Why?
|
| Cohort Studies | 3 | 2024 | 1759 | 0.310 |
Why?
|
| Antihypertensive Agents | 2 | 2002 | 287 | 0.310 |
Why?
|
| Coronary Stenosis | 1 | 2010 | 37 | 0.310 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2020 | 10 | 0.290 |
Why?
|
| Chickens | 2 | 2021 | 161 | 0.290 |
Why?
|
| Pericardiectomy | 2 | 2020 | 2 | 0.280 |
Why?
|
| Pericarditis, Constrictive | 2 | 2020 | 3 | 0.280 |
Why?
|
| Atherosclerosis | 2 | 2022 | 169 | 0.250 |
Why?
|
| Brachial Artery | 2 | 2003 | 27 | 0.240 |
Why?
|
| Vasodilation | 2 | 2003 | 64 | 0.240 |
Why?
|
| Chromatin | 2 | 2024 | 186 | 0.230 |
Why?
|
| Genes, Mitochondrial | 1 | 2025 | 14 | 0.230 |
Why?
|
| Heart Atria | 2 | 2015 | 29 | 0.230 |
Why?
|
| Hypertension | 2 | 2002 | 835 | 0.230 |
Why?
|
| Young Adult | 9 | 2020 | 5080 | 0.230 |
Why?
|
| Early Detection of Cancer | 2 | 2021 | 449 | 0.220 |
Why?
|
| CpG Islands | 2 | 2022 | 109 | 0.220 |
Why?
|
| MicroRNAs | 2 | 2022 | 518 | 0.210 |
Why?
|
| Observer Variation | 3 | 2015 | 59 | 0.210 |
Why?
|
| Cause of Death | 1 | 2025 | 186 | 0.210 |
Why?
|
| Survival Rate | 1 | 2025 | 355 | 0.210 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 65 | 0.200 |
Why?
|
| Lymphatic Metastasis | 2 | 2022 | 81 | 0.200 |
Why?
|
| Pregnancy | 3 | 2025 | 1772 | 0.200 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2003 | 8 | 0.200 |
Why?
|
| Thoracic Injuries | 1 | 2003 | 11 | 0.200 |
Why?
|
| Heart Aneurysm | 1 | 2003 | 2 | 0.200 |
Why?
|
| Pericarditis | 1 | 2003 | 3 | 0.200 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 30 | 0.200 |
Why?
|
| Renal Artery Obstruction | 1 | 2022 | 5 | 0.190 |
Why?
|
| Incidence | 1 | 2026 | 1078 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 67 | 0.190 |
Why?
|
| Melanoma | 1 | 2024 | 110 | 0.190 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.190 |
Why?
|
| Case-Control Studies | 6 | 2022 | 1285 | 0.190 |
Why?
|
| Death, Sudden | 1 | 2002 | 4 | 0.180 |
Why?
|
| Bradycardia | 1 | 2002 | 9 | 0.180 |
Why?
|
| Adolescent | 9 | 2018 | 6081 | 0.180 |
Why?
|
| Methyltransferases | 1 | 2022 | 68 | 0.180 |
Why?
|
| Workflow | 1 | 2022 | 26 | 0.180 |
Why?
|
| Quality Control | 1 | 2021 | 42 | 0.180 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 115 | 0.180 |
Why?
|
| Endometrium | 1 | 2022 | 59 | 0.180 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2013 | 3 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 223 | 0.180 |
Why?
|
| Mitochondria | 1 | 2025 | 523 | 0.170 |
Why?
|
| Immunologic Factors | 1 | 2021 | 51 | 0.170 |
Why?
|
| Relaxin | 1 | 2021 | 10 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 203 | 0.170 |
Why?
|
| Hospitalization | 1 | 2025 | 485 | 0.170 |
Why?
|
| Adenosylhomocysteinase | 1 | 2020 | 2 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2020 | 238 | 0.170 |
Why?
|
| Databases as Topic | 1 | 2020 | 25 | 0.170 |
Why?
|
| Rabbits | 3 | 2022 | 278 | 0.170 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2020 | 16 | 0.170 |
Why?
|
| Cerebral Infarction | 1 | 2020 | 19 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 587 | 0.170 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 218 | 0.170 |
Why?
|
| Meta-Analysis as Topic | 1 | 2020 | 35 | 0.160 |
Why?
|
| Proteomics | 1 | 2023 | 378 | 0.160 |
Why?
|
| Microarray Analysis | 1 | 2020 | 64 | 0.160 |
Why?
|
| Genetic Markers | 1 | 2020 | 150 | 0.160 |
Why?
|
| RNA | 1 | 2022 | 266 | 0.160 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 74 | 0.160 |
Why?
|
| Animals | 9 | 2022 | 16992 | 0.160 |
Why?
|
| Databases, Genetic | 1 | 2020 | 103 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 196 | 0.160 |
Why?
|
| Norepinephrine | 2 | 2022 | 97 | 0.150 |
Why?
|
| Lung | 1 | 2022 | 492 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 301 | 0.150 |
Why?
|
| Survival Analysis | 1 | 2020 | 368 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 734 | 0.150 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 386 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2022 | 561 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2019 | 34 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 228 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2019 | 53 | 0.140 |
Why?
|
| Uterus | 1 | 2018 | 52 | 0.140 |
Why?
|
| Egg Shell | 1 | 2018 | 35 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 526 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 51 | 0.140 |
Why?
|
| Child | 4 | 2016 | 3443 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2019 | 112 | 0.130 |
Why?
|
| Sprains and Strains | 1 | 2016 | 3 | 0.130 |
Why?
|
| China | 4 | 2020 | 229 | 0.120 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 13 | 0.120 |
Why?
|
| Liver | 1 | 2019 | 511 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1766 | 0.120 |
Why?
|
| Statistics as Topic | 2 | 2013 | 123 | 0.110 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 1070 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 760 | 0.110 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1019 | 0.110 |
Why?
|
| Arteries | 1 | 2015 | 81 | 0.110 |
Why?
|
| Myocardium | 1 | 2016 | 263 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 206 | 0.100 |
Why?
|
| Heart Transplantation | 1 | 2013 | 47 | 0.100 |
Why?
|
| Infusions, Intravenous | 2 | 2003 | 53 | 0.100 |
Why?
|
| Algorithms | 3 | 2021 | 509 | 0.100 |
Why?
|
| Fetofetal Transfusion | 1 | 2012 | 2 | 0.090 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 42 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1455 | 0.090 |
Why?
|
| Cold Temperature | 2 | 2002 | 40 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 72 | 0.090 |
Why?
|
| ROC Curve | 2 | 2023 | 159 | 0.090 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 2676 | 0.090 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2010 | 1 | 0.080 |
Why?
|
| Oviposition | 2 | 2021 | 14 | 0.080 |
Why?
|
| Reference Standards | 1 | 2010 | 55 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2018 | 2157 | 0.080 |
Why?
|
| Blood Pressure | 2 | 2002 | 666 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2003 | 1546 | 0.070 |
Why?
|
| Elasticity | 2 | 2016 | 53 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2010 | 185 | 0.060 |
Why?
|
| Reference Values | 2 | 2015 | 211 | 0.060 |
Why?
|
| Anthracyclines | 1 | 2023 | 8 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2025 | 247 | 0.050 |
Why?
|
| Diastole | 1 | 2023 | 47 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 45 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2023 | 51 | 0.050 |
Why?
|
| gamma-Globulins | 1 | 2003 | 5 | 0.050 |
Why?
|
| Nitroglycerin | 1 | 2003 | 7 | 0.050 |
Why?
|
| Systole | 2 | 2013 | 67 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2023 | 33 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2003 | 87 | 0.050 |
Why?
|
| Kidney Cortex | 1 | 2022 | 8 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2025 | 195 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2002 | 17 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2003 | 54 | 0.050 |
Why?
|
| Disease Progression | 1 | 2025 | 667 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2023 | 119 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 236 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2022 | 100 | 0.050 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2022 | 14 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2023 | 171 | 0.050 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2022 | 27 | 0.050 |
Why?
|
| 5-Methylcytosine | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pedigree | 1 | 2002 | 94 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 157 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 82 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 69 | 0.040 |
Why?
|
| Eggs | 1 | 2021 | 14 | 0.040 |
Why?
|
| Oviducts | 1 | 2021 | 13 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 423 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 310 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2021 | 272 | 0.040 |
Why?
|
| Genome, Human | 1 | 2021 | 144 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 249 | 0.040 |
Why?
|
| Cattle | 1 | 2022 | 498 | 0.040 |
Why?
|
| Heart Rate | 1 | 2002 | 266 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 515 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 549 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2019 | 74 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 863 | 0.040 |
Why?
|
| Molting | 1 | 2018 | 8 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2019 | 259 | 0.040 |
Why?
|
| DNA | 1 | 2021 | 592 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2022 | 1271 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 149 | 0.030 |
Why?
|
| Base Sequence | 1 | 2018 | 983 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 456 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 10 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2018 | 536 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2015 | 20 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 164 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 712 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2013 | 12 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 174 | 0.020 |
Why?
|
| Twins, Monozygotic | 1 | 2012 | 10 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 1063 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2015 | 925 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 518 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 575 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2010 | 12 | 0.020 |
Why?
|
| Mice | 1 | 2022 | 6644 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 30 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3156 | 0.020 |
Why?
|
| Computer Systems | 1 | 2008 | 19 | 0.020 |
Why?
|
| Swine | 1 | 2008 | 212 | 0.020 |
Why?
|